Page last updated: 2024-11-06

thyroxine and Multiple Endocrine Neoplasia Type 1

thyroxine has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).

Research Excerpts

ExcerptRelevanceReference
"Two women had sporadic multiple endocrine neoplasia type 1-associated syndrome."1.32The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. ( Beckers, A; Chanson, P; Delemer, B; Mockel, J; Rohmer, V; Socin, HV; Stevenaert, A; Tabarin, A, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Socin, HV1
Chanson, P1
Delemer, B1
Tabarin, A1
Rohmer, V1
Mockel, J1
Stevenaert, A1
Beckers, A1

Other Studies

1 other study available for thyroxine and Multiple Endocrine Neoplasia Type 1

ArticleYear
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    European journal of endocrinology, 2003, Volume: 148, Issue:4

    Topics: Acromegaly; Adenoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Belgium; Femal

2003